Feb 5 (Reuters) - GSK forecast sales in 2025 to grow between 3% and 5%, and reported a better-than-expected fourth quarter earnings, as strength in its HIV and oncology portfolio offset weakness in its vaccines division. The company reported core earnings per share of 23.2 pence on sales of 8.12 billion pounds ($10.13 billion) for the quarter ended Dec. 31,...

SINGAPORE/CANBERRA (Reuters) - China has delayed imports of up to 600,000 metric tons of mostly Australian wheat and offered some of these cargoes to other buyers as ample domestic supplies reduce demand in the world's top buyer of the grain, two trade sources with direct knowledge of the matter said. China accounted for 6% of global wheat imports in the...

LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow that is likely to deepen investor concerns that the company is losing its edge in the competitive obesity market to rival Eli Lilly. The Danish company said it expects sales growth this year between 16% and 24%, a weaker forecast than it...

SHANGHAI (Reuters) - Chinese companies, from chip makers to cloud service providers, are rushing to support DeepSeek's artificial intelligence models, spurring analysts to hail a watershed moment for the industry. Moore Threads and Hygon Information Technology, which makes AI chips and looks to compete with Nvidia, said on Monday their computing clusters and accelerators would be able to support DeepSeek's...